ClinicaliQ Trial Snapshot
- Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis — Recruiting • Phase II • Dermatology • NCT06947993.
- Multi-drug trial testing new treatments for moderate to severe eczema in adults.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD). Conditions: Atopic Dermatitis Interventions: GHZ339, Placebo Lead Sponsor: Novartis Pharmaceuticals Planned Enrollment: 224 participants